Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Bio-Techne (TECH) Long-Term Deferred Tax (2025)

Historic Long-Term Deferred Tax for Bio-Techne (TECH) over the last 3 years, with Q2 2025 value amounting to $10.3 million.

Bio-Techne's Long-Term Deferred Tax changed N/A to $10.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $10.3 million, marking a year-over-year change of. This contributed to the annual value of $10.3 million for FY2025, which is N/A changed from last year.
Latest data reveals that Bio-Techne reported Long-Term Deferred Tax of $10.3 million as of Q2 2025.
Over the past 5 years, Bio-Techne's Long-Term Deferred Tax peaked at $10.3 million during Q2 2025, and registered a low of $10.3 million during Q2 2025.